申请人:——
公开号:US20030055080A1
公开(公告)日:2003-03-20
A compound according to formula (I)
1
wherein:
is a phenyl ring, a C
4
to C
9
heteroaromatic compound containing one or more heteroatoms, or a naphthalenyl, 5,6,7,8-tetrahydronaphthalenyl or biphenyl group;
R
1
, R
2
and R
3
each independently represent a hydrogen or halogen atom, or a hydroxy group, or a phenyl, —OR
4
, —SR
4
, —NR
4
R
5
, —NHCOR
4
, —CONR
4
R
5
, —CN, —NO
2
, —COOR
4
or —CF
3
group, or a straight or branched lower alkyl group which may optionally be substituted, for example, with a hydroxy or alcoxy group, wherein R
4
and R
5
each independently represent a hydrogen atom, straight or branched lower alkyl group, or together form an alicyclic ring; or R
1
and R
2
together form an aromatic, alicyclic or heterocyclic ring;
n is an integer from 0 to 4;
A represents a —CH
2
—, —CH═CR
6
, —CR
6
=CH—, —CR
6
R
7
—, —CO—, —O—, —S—, —S(O)—, SO
2
or —NR
6
— group, wherein R
6
and R
7
each independently represent a hydrogen atom, straight or branched lower alkyl group, or R
6
and R
7
together form an alicyclic ring;
m is an integer from 0 to 8; provided that when m=
0
, A is not —CH
2
—;
p is an integer from 1 to 2 and the substitution in the azoniabicyclic ring may be in the 2, 3 or 4 position including all possible configurations of the asymmetric carbons;
B represents a group of formula i) or ii):
2
wherein R
10
represents a hydrogen atom, a hydroxy or methyl group; and R
8
and R
9
each independently represents
3
wherein R
11
represents a hydrogen or halogen atom, or a straight or branched lower alkyl group and Q represents a single bond, —CH
2
—, —CH
2
—CH
2
—, —O—, —O—CH
2
—, —S—, —S—CH
2
— or —CH═CH—, and when i) or ii) contain a chiral centre they may represent either configuration;
X represents a pharmaceutically acceptable anion of a mono or polyvalent acid,
which shows high affinity for muscarinic M
3
receptors (Hm3).
根据公式(I)1,其中:是苯环,含有一个或多个杂原子的C4至C9杂芳族化合物,或者是萘基、5,6,7,8-四氢萘基或联苯基;R1、R2和R3分别独立表示氢或卤素原子,或羟基,或苯基,—OR4,—SR4,—NR4R5,—NHCOR4,—CONR4R5,—CN,—NO2,—COOR4或—CF3基团,或直链或支链的较低烷基基团,该基团可以选择性地被取代,例如,取代物可以是羟基或醇基,其中R4和R5分别独立表示氢原子,直链或支链较低烷基基团,或者共同形成脂环;或R1和R2共同形成芳香族、脂环或杂环;n是从0到4的整数;A表示—CH2—,—CH═CR6,—CR6=CH—,—CR6R7—,—CO—,—O—,—S—,—S(O)—,SO2或—NR6—基团,其中R6和R7分别独立表示氢原子,直链或支链较低烷基基团,或R6和R7共同形成脂环;m是从0到8的整数;但是当m=0时,A不是—CH2—;p是从1到2的整数,而在azoniabicyclic环中的取代物可以在2、3或4位置,包括所有可能的手性碳的构型;B表示i)或ii)式的基团,其中R10表示氢原子,羟基或甲基基团;而R8和R9分别表示,其中R11表示氢或卤素原子,或直链或支链较低烷基基团,Q表示单键,—CH2—,—CH2—CH2—,—O—,—O—CH2—,—S—,—S—CH2—或—CH═CH—,当i)或ii)含有手性中心时,它们可以代表任何构型;X表示单价或多价酸的药学上可接受的阴离子,该阴离子对Hm3亲和力高的胆碱能M3受体具有高亲和力。